30
Participants
Start Date
July 31, 2000
Primary Completion Date
September 30, 2003
Study Completion Date
September 30, 2003
temozolomide
Ireland Cancer Center, Cleveland
Collaborators (1)
National Cancer Institute (NCI)
NIH
Schering-Plough
INDUSTRY
Case Comprehensive Cancer Center
OTHER